Engineered probiotics for tumor-targeted combination chemoimmunotherapy
- DOI
- 10.1126/scitranslmed.ady2289
- Published
- 2026-09-16
- Container
- Science Translational Medicine
- Publisher
- American Association for the Advancement of Science (AAAS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1126/scitranslmed.ady2289,
title = {Engineered probiotics for tumor-targeted combination chemoimmunotherapy},
author = {Zaofeng Yang and Jongwon Im and Noah Chen and Dylan L. Mariuzza and Kenia de los Santos-Alexis and Fangda Li and Edward R. Ballister and Olivia R. Ringham and Tal Danino and Nicholas Arpaia},
year = {2026},
journal = {Science Translational Medicine},
doi = {10.1126/scitranslmed.ady2289},
url = {https://doi.org/10.1126/scitranslmed.ady2289}
}RIS
TY - JOUR TI - Engineered probiotics for tumor-targeted combination chemoimmunotherapy AU - Zaofeng Yang AU - Jongwon Im AU - Noah Chen AU - Dylan L. Mariuzza AU - Kenia de los Santos-Alexis AU - Fangda Li AU - Edward R. Ballister AU - Olivia R. Ringham AU - Tal Danino AU - Nicholas Arpaia PY - 2026 JO - Science Translational Medicine DO - 10.1126/scitranslmed.ady2289 UR - https://doi.org/10.1126/scitranslmed.ady2289 ER -
APA
Yang, Z., Im, J., Chen, N., Mariuzza, D. L., Santos-Alexis, K. D. L., Li, F., Ballister, E. R., Ringham, O. R., Danino, T., & Arpaia, N. (2026). Engineered probiotics for tumor-targeted combination chemoimmunotherapy. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ady2289
Source records
- crossref · retrieved 2026-09-25T18:34:20.967Z